Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-03

FDA Approved: VIGABATRIN — Original Application (Cipla USA, Inc.)

View source ↗

Summary

FDA approved the original generic application for vigabatrin submitted by Cipla USA, establishing a generic version of the anticonvulsant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

ORIG AP for VIGABATRIN (VIGABATRIN)